MEDS Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
-$1.04
Past Year
-$26.96
Growth Past 5yrs
N/A
Next Quarter
-
Estimate Next Year
-
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
(
0% Upside
)Mean Price Target
N/A
(
0% Upside
)Lowest Price Target
N/A
(
0% Upside
)Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
MEDS Earnings Per Share (EPS) History
According to financial reports, MEDS (NYSE: MEDS) reported an actual EPS of $-1.04 for the quarter ending on Aug 09, 2024, compared to an estimated $-0.15, resulting in a 593.33% surprise. In the prior quarter (Jun 26, 2024), MEDS recorded an actual EPS of $-6.4 with a 4166.67% surprise. See MEDS's full earnings history.
Earnings History
EPS Surprise Factor Analysis
MEDS has experienced notable EPS surprises, with the latest quarter ending Aug 09, 2024 showing a 593.33% beat. Previously, the quarter ending Jun 26, 2024 recorded a 4166.67% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
Frequently Asked Questions
Is MEDS stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given MEDS stock an average recommendation of
N/A. 0 analysts have given their ratings
to MEDS out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for MEDS highest price target?
Analysts suggest MEDS's stock price would rise to a high of -.
What is the lowest price target analysts expect for MEDS over the next year?
Within the next 12 months, analysts predict the MEDS stock price could move to -.
What is the average target price for MEDS?
MEDS stock has an average analyst estimate of -.
At its current price, how far is MEDS from its average target price?
MEDS shares are currently trading 0% below this price target.
What were MEDS’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at -$1.04 versus consensus estimates of -$0.15, and below the comparable year-ago quarter’s EPS of -$0.90.
What are the current estimates for quarterly and annual earnings per share?
MEDS's forecasts by analysts estimating quarterly EPS at - and - for the whole year.
What has MEDS's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for MEDS in the next five years, compared to growth rates of N/A in the past five years.